Attenuated dengue virus comprising mutations in the NS3 gene
US7560118B2 · kind B2 · utility
7Cited by
3References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 2, 2006 |
| Grant date | Jul 14, 2009 |
| Priority date | — |
| Expiry date | Nov 12, 2026 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A menu of mutations was developed that is useful in fine-tuning the attenuation and growth characteristics of dengue virus vaccines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.